Clinical Trial Update: APG101 in Glioblastoma [Phase 2]

View source ↗

Summary

The Phase 2 trial of APG101 in glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• APG101

Snippet

Sponsor: Apogenix GmbH | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED